BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33040219)

  • 1. Cardiac Tumors: Diagnosis, Prognosis, and Treatment.
    Bussani R; Castrichini M; Restivo L; Fabris E; Porcari A; Ferro F; Pivetta A; Korcova R; Cappelletto C; Manca P; Nuzzi V; Bessi R; Pagura L; Massa L; Sinagra G
    Curr Cardiol Rep; 2020 Oct; 22(12):169. PubMed ID: 33040219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac tumors: three decades of experience from a tertiary center: are we changing diagnostic work-up with new imaging tools?
    Mendes GS; Abecasis J; Ferreira A; Ribeiras R; Abecasis M; Gouveia R; Andrade MJ; Mendes M; Ramos S; Saraiva C; Neves JP
    Cardiovasc Pathol; 2020; 49():107242. PubMed ID: 32629212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and limitations of multimodality imaging in the diagnosis of a primary cardiac lymphoma.
    Nijjar PS; Masri SC; Tamene A; Kassahun H; Liao K; Valeti U
    Tex Heart Inst J; 2014 Dec; 41(6):657-9. PubMed ID: 25593536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-modality Imaging Assessment of Pericardial Masses.
    Zhou W; Srichai MB
    Curr Cardiol Rep; 2017 Apr; 19(4):32. PubMed ID: 28315124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac myxoma: a contemporary multimodality imaging review.
    Colin GC; Gerber BL; Amzulescu M; Bogaert J
    Int J Cardiovasc Imaging; 2018 Nov; 34(11):1789-1808. PubMed ID: 29974293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution and performance of multimodal imaging in the diagnosis and management of cardiac masses.
    Lemasle M; Lavie Badie Y; Cariou E; Fournier P; Porterie J; Rousseau H; Petermann A; Hitzel A; Carrié D; Galinier M; Marcheix B; Lairez O
    Int J Cardiovasc Imaging; 2020 May; 36(5):971-981. PubMed ID: 32040684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging findings in cardiac masses (Part I): study protocol and benign tumors.
    Díaz Angulo C; Méndez Díaz C; Rodríguez García E; Soler Fernández R; Rois Siso A; Marini Díaz M
    Radiologia; 2015; 57(6):480-8. PubMed ID: 26307666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac MRI is complementary to echocardiography in the assessment of cardiac masses.
    Altbach MI; Squire SW; Kudithipudi V; Castellano L; Sorrell VL
    Echocardiography; 2007 Mar; 24(3):286-300. PubMed ID: 17313646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Tumors:
    Tyebally S; Chen D; Bhattacharyya S; Mughrabi A; Hussain Z; Manisty C; Westwood M; Ghosh AK; Guha A
    JACC CardioOncol; 2020 Jun; 2(2):293-311. PubMed ID: 34396236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodality Imaging to Characterize a Metastatic Cardiac Mass.
    Yarlagadda B; Paleti S; Annamalai SK
    Echocardiography; 2016 May; 33(5):804-5. PubMed ID: 26753912
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular magnetic resonance of cardiac tumors and masses.
    Gatti M; D'Angelo T; Muscogiuri G; Dell'aversana S; Andreis A; Carisio A; Darvizeh F; Tore D; Pontone G; Faletti R
    World J Cardiol; 2021 Nov; 13(11):628-649. PubMed ID: 34909128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac MRI-based multi-modality imaging in clinical decision-making: Preliminary assessment of a management algorithm for patients with suspected cardiac mass.
    Zhu D; Yin S; Cheng W; Luo Y; Yang D; Lin K; An Q; Sun J; Chen Y
    Int J Cardiol; 2016 Jan; 203():474-81. PubMed ID: 26551882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late Gadolinium Enhancement Cardiac Magnetic Resonance Tissue Characterization for Cancer-Associated Cardiac Masses: Metabolic and Prognostic Manifestations in Relation to Whole-Body Positron Emission Tomography.
    Chan AT; Fox J; Perez Johnston R; Kim J; Brouwer LR; Grizzard J; Kim RJ; Matasar M; Shia J; Moskowitz CS; Steingart R; Weinsaft JW
    J Am Heart Assoc; 2019 May; 8(10):e011709. PubMed ID: 31072171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated 18F-FDG PET/MR imaging in the assessment of cardiac masses: a pilot study.
    Nensa F; Tezgah E; Poeppel TD; Jensen CJ; Schelhorn J; Köhler J; Heusch P; Bruder O; Schlosser T; Nassenstein K
    J Nucl Med; 2015 Feb; 56(2):255-60. PubMed ID: 25552667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiac masses: classification, clinical features and diagnostic approach].
    Angeli F; Fabrizio M; Paolisso P; Magnani I; Bergamaschi L; Bartoli L; Stefanizzi A; Armillotta M; Sansonetti A; Amicone S; Impellizzeri A; Tattilo FP; Suma N; Bodega F; Canton L; Rinaldi A; Foà A; Pizzi C
    G Ital Cardiol (Rome); 2022 Aug; 23(8):620-630. PubMed ID: 36169142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of malignant and benign cardiac tumors using 18F-FDG PET/CT.
    Rahbar K; Seifarth H; Schäfers M; Stegger L; Hoffmeier A; Spieker T; Tiemann K; Maintz D; Scheld HH; Schober O; Weckesser M
    J Nucl Med; 2012 Jun; 53(6):856-63. PubMed ID: 22577239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality imaging and histopathology of cardiac myeloid sarcoma.
    Wang Y; Wu W; Zhong D; Han X; Fang L
    Eur Heart J Cardiovasc Imaging; 2016 Nov; 17(11):1316. PubMed ID: 27458183
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac and pericardial tumors: A potential application of positron emission tomography-magnetic resonance imaging.
    Fathala A; Abouzied M; AlSugair AA
    World J Cardiol; 2017 Jul; 9(7):600-608. PubMed ID: 28824790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cardiac masses by CMR-strengths and pitfalls: a tertiary center experience.
    Tumma R; Dong W; Wang J; Litt H; Han Y
    Int J Cardiovasc Imaging; 2016 Jun; 32(6):913-20. PubMed ID: 26838354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality Imaging for the Assessment of Pericardial Diseases.
    Chetrit M; Xu B; Verma BR; Klein AL
    Curr Cardiol Rep; 2019 Apr; 21(5):41. PubMed ID: 30993456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.